Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

AXGN

Axogen Inc

Feb 11 • 03:34PM ET

34.16

-0.35 -1.01 %

Healthcare • Medical Devices • USA • NASD

Peers: IART BAX SYK ZBH MDT JNJ GMED EW PODD HOLX

| Held by: VTI IWM VXF IWO SCHA FESM IHI VTWO VHT IWC

Index	RUT	P/E	-	EPS (ttm)	-0.05	Insider Own	2.07%	Shs Outstand	50.12M	Perf Week	-0.18%
Market Cap	1.71B	Forward P/E	70.96	EPS next Y	0.48	Insider Trans	-31.70%	Shs Float	49.08M	Perf Month	8.27%
Enterprise Value	1.74B	PEG	0.87	EPS next Q	0.06	Inst Own	85.21%	Short Float	5.61%	Perf Quarter	42.33%
Income	-2.10M	P/S	7.97	EPS this Y	115.45%	Inst Trans	2.22%	Short Ratio	2.98	Perf Half Y	141.24%
Sales	214.71M	P/B	13.04	EPS next Y	71.89%	ROA	-1.03%	Short Interest	2.75M	Perf YTD	4.37%
Book/sh	2.62	P/C	43.03	EPS next 5Y	81.49%	ROE	-1.90%	52W High	36.00 -5.11%	Perf Year	94.98%
Cash/sh	0.79	P/FCF	512.63	EPS past 3/5Y	29.94% 21.24%	ROIC	-1.13%	52W Low	9.22 270.70%	Perf 3Y	276.63%
Dividend Est.	-	EV/EBITDA	153.87	Sales past 3/5Y	13.73% 11.91%	Gross Margin	74.76%	Volatility	4.64% 4.66%	Perf 5Y	76.36%
Dividend TTM	-	EV/Sales	8.11	EPS Y/Y TTM	85.77%	Oper. Margin	1.79%	ATR (14)	1.71	Perf 10Y	583.20%
Dividend Ex-Date	Jan 27, 2010	Quick Ratio	2.64	Sales Y/Y TTM	18.72%	Profit Margin	-0.98%	RSI (14)	55.10	Recom	1.27
Dividend Gr. 3/5Y	- -	Current Ratio	4.09	EPS Q/Q	134.04%	SMA20	1.83%	Beta	0.97	Target Price	36.60
Payout	-	Debt/Eq	0.56	Sales Q/Q	23.51%	SMA50	5.85%	Rel Volume	1.06	Prev Close	34.51
Employees	452	LT Debt/Eq	0.54	Earnings	Feb 24 BMO	SMA200	72.95%	Avg Volume	923.57K	Price	34.16
IPO	Dec 17, 1986	Option/Short	Yes / Yes	EPS/Sales Surpr.	66.20% 5.51%	Trades		Volume	920,401	Change	-1.01%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-01-25	Initiated	Mizuho	Outperform	$40
Mar-17-25	Initiated	Lake Street	Buy	$30
Jul-01-24	Initiated	Raymond James	Outperform	$13
Nov-11-22	Resumed	Jefferies	Buy	$15
May-09-22	Upgrade	Canaccord Genuity	Hold → Buy	$10 → $15
Mar-11-22	Resumed	Cantor Fitzgerald	Overweight	$21
Oct-23-20	Initiated	Guggenheim	Buy	$24
Jun-16-20	Resumed	Cantor Fitzgerald	Overweight	$16
May-07-20	Downgrade	Canaccord Genuity	Buy → Hold	$12
Apr-02-20	Downgrade	BTIG Research	Buy → Neutral
Aug-07-19	Downgrade	William Blair	Outperform → Mkt Perform
Jul-12-19	Initiated	Canaccord Genuity	Buy	$32
Mar-02-18	Reiterated	Lake Street	Buy	$26 → $38
Jan-05-18	Resumed	Cantor Fitzgerald	Overweight
Nov-30-17	Initiated	Jefferies	Buy	$35
Nov-21-17	Reiterated	Lake Street	Buy	$22 → $26
Jul-31-17	Initiated	Leerink Partners	Outperform	$22
Jun-30-17	Initiated	Cantor Fitzgerald	Overweight	$18
Mar-06-17	Initiated	ROTH Capital	Buy	$14.50
Nov-22-16	Upgrade	Lake Street	Hold → Buy	$9 → $11

Show Previous Ratings

Feb-10-26 07:00AM	Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (GlobeNewswire)
Jan-22-26 12:42PM	Axogen Prices Upsized $124 Million Stock Offering (Benzinga)
Jan-21-26 11:18PM	Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock (GlobeNewswire)
04:09PM	Axogen Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jan-15-26 03:07PM	AxoGen Touts Post-BLA Growth Plan, 75%+ Gross Margin Outlook at J.P. Morgan Healthcare Conference (MarketBeat)
07:00AM	Loading…
Jan-12-26 07:00AM	Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025 (GlobeNewswire) -5.85%
Dec-17-25 07:00AM	Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference (GlobeNewswire) +6.95%
Dec-03-25 08:01PM	Axogen Announces FDA Approval of Biologics License Application for AVANCE (acellular nerve allograft-arwx) (GlobeNewswire) +15.97%
Nov-04-25 07:00AM	Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences (GlobeNewswire)
Oct-29-25 08:15AM	AxoGen (AXGN) Q3 Earnings and Revenues Top Estimates (Zacks) +23.06%
07:13AM	AxoGen: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Axogen, Inc. Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-15-25 07:00AM	Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025 (GlobeNewswire)
Oct-06-25 08:04AM	CLPT Expands Into Robotic System Supporting Cell and Gene Therapies (Zacks)
Sep-26-25 09:21AM	GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent (Zacks)
09:24AM	Loading…
Sep-25-25 09:24AM	Masimo Completes Divestment of Consumer Audio Business to HARMAN (Zacks)
Sep-23-25 08:21AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
Sep-12-25 09:40AM	Are Medical Stocks Lagging AxoGen (AXGN) This Year? (Zacks)
Aug-28-25 09:55AM	Does AxoGen (AXGN) Have the Potential to Rally 53.1% as Wall Street Analysts Expect? (Zacks)
Aug-27-25 08:00AM	Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences (GlobeNewswire)
Aug-25-25 04:04PM	Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted (Investor's Business Daily) -9.04% +9.60%
10:39AM	FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months (Benzinga)
06:40AM	Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft (GlobeNewswire)
Aug-20-25 09:13AM	Axogen (AXGN) Slid on a Weaker Than Expected Gross Margin (Insider Monkey)
Aug-13-25 12:08PM	Raymond James Slashes PT on Axogen (AXGN) to $20 From $21 (Insider Monkey)
Aug-12-25 09:55AM	Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know (Zacks)
Aug-05-25 08:15AM	AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates (Zacks) +9.32%
07:21AM	AxoGen: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Axogen, Inc. Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 07:10AM	Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
10:00AM	Loading…
Jul-30-25 10:00AM	Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-29-25 04:10PM	Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
10:00AM	AxoGen (AXGN) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-22-25 04:05PM	Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025 (GlobeNewswire) +8.01% +7.34%
Jul-02-25 10:06PM	Axogen Showcases Nerve Repair Vision at Goldman Sachs (Insider Monkey)
May-28-25 08:00AM	Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference (GlobeNewswire)
May-21-25 09:35AM	AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
May-09-25 09:45AM	Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline (Zacks) -9.73%
09:30AM	MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off (Zacks)
03:08AM	Axogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid ... (GuruFocus.com)
May-08-25 08:30AM	AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -23.18%
07:28AM	AxoGen: Q1 Earnings Snapshot (Associated Press Finance)
07:05AM	Axogen, Inc. Reports 2025 First Quarter Financial Results (GlobeNewswire)
07:00AM	Axogen Announces Chief Financial Officer Transition (GlobeNewswire)
May-07-25 06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
01:09PM	COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised (Zacks)
12:31PM	AxoGen Q1 2025 Earnings Preview (Seeking Alpha)
May-02-25 01:22PM	SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS View (Zacks)
01:21PM	DexCom Stock Rises Despite Q1 Earnings Miss & Lower Margins (Zacks)
Apr-24-25 08:04AM	Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025 (GlobeNewswire)
Mar-31-25 03:03PM	Stryker Stock Gets Relative Strength Rating Lift (Investor's Business Daily)
Mar-25-25 11:12AM	Axogen: LT Bullish, But Outcomes Weighted To Downside, At This Point (SeekingAlpha)
Mar-24-25 08:00AM	Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-04-25 03:04PM	Alcon Stock Gets Relative Strength Rating Lift (Investor's Business Daily)
Feb-26-25 02:03AM	Axogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ... (GuruFocus.com)
12:27AM	Q4 2024 AxoGen Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-25-25 07:41AM	AxoGen: Q4 Earnings Snapshot (Associated Press Finance) +11.66%
07:10AM	Axogen, Inc. To Host Analyst & Investor Day on March 4th (GlobeNewswire)
07:00AM	Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results (GlobeNewswire)
Feb-11-25 04:58PM	Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025 (GlobeNewswire)
Feb-03-25 08:00AM	Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-13-25 09:35AM	AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out? (Zacks)
05:05AM	AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last? (Zacks)
Jan-10-25 05:00PM	Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +18.21%
08:00AM	Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024 (GlobeNewswire)
Dec-24-24 09:15AM	AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run? (Zacks) -5.41%
Dec-19-24 09:40AM	Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Nov-28-24 12:00PM	All You Need to Know About AxoGen (AXGN) Rating Upgrade to Buy (Zacks)
Nov-25-24 09:55AM	How Much Upside is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18% (Zacks)
Nov-08-24 07:35AM	AxoGen Reports Strong Q3 2024 Revenue Growth (TipRanks)
02:08AM	Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements (GuruFocus.com)
Nov-07-24 07:48AM	AxoGen: Q3 Earnings Snapshot (Associated Press Finance) -13.44%
07:00AM	Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update (GlobeNewswire)
Oct-24-24 07:00AM	Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024 (GlobeNewswire)
Oct-14-24 07:21AM	AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains? (Zacks)
Oct-09-24 05:30PM	Axogen Inc (AXGN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... (GuruFocus.com)
Sep-12-24 01:30AM	ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc (GuruFocus.com)
Sep-06-24 07:00AM	Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft (GlobeNewswire)
Sep-04-24 09:15AM	AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue? (Zacks)
Sep-03-24 07:00AM	Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4) (GlobeNewswire)
Aug-30-24 12:00PM	What Makes AxoGen (AXGN) a Strong Momentum Stock: Buy Now? (Zacks)
Aug-23-24 09:55AM	Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High? (Zacks)
Aug-19-24 09:15AM	AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run? (Zacks)
Aug-13-24 04:18PM	CytoSorbents Appoints Peter J. Mariani Chief Financial Officer (GlobeNewswire)
Aug-09-24 12:56AM	Axogen names ex-Abbott exec Michael Dale as CEO (MedTech Dive)
Aug-08-24 08:20AM	AxoGen (AXGN) Q2 Earnings and Revenues Beat Estimates (Zacks) +35.10%
07:19AM	AxoGen: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Axogen, Inc. Announces New Leadership Appointments (GlobeNewswire)
07:00AM	Axogen, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-01-24 10:01AM	AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks) -7.06%
Jul-23-24 07:00AM	Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 (GlobeNewswire)
Jul-12-24 08:37AM	AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock? (Zacks)
Jul-01-24 07:00AM	Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire) +6.49%
Jun-25-24 12:52PM	AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection (Zacks)
Jun-24-24 07:00AM	Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix (GlobeNewswire)
Jun-12-24 04:56AM	Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength? (Zacks) +9.21%
May-28-24 04:30PM	Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia (GlobeNewswire) +5.90%
May-17-24 12:29PM	AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft (Zacks)
May-16-24 02:56PM	AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft (MT Newswires)
07:00AM	Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft (GlobeNewswire)

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm's products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wendell Amy McBride	Director	Dec 16 '25	Option Exercise	6.91	43,684	301,963	137,510	Dec 17 04:25 PM
Wendell Amy McBride	Director	Dec 16 '25	Sale	29.31	43,684	1,280,465	93,826	Dec 17 04:25 PM
Weiler Kathy Johnson	Director	Dec 16 '25	Option Exercise	6.99	40,073	280,150	46,653	Dec 17 04:25 PM
Weiler Kathy Johnson	Director	Dec 16 '25	Sale	29.55	46,653	1,378,476	0	Dec 17 04:25 PM
Hartley Lindsey Marie	CFO	Dec 15 '25	Option Exercise	8.27	14,812	122,495	46,188	Dec 17 04:24 PM
Hartley Lindsey Marie	CFO	Dec 15 '25	Sale	29.86	14,812	442,294	31,376	Dec 17 04:24 PM
Amy McBride-Wendell	Director	Dec 16 '25	Proposed Sale	29.31	43,684	1,280,461		Dec 16 05:03 PM
KATHY WEILER	Director	Dec 16 '25	Proposed Sale	29.55	46,653	1,378,484		Dec 16 04:27 PM
LINDSEY MARIE HARTLEY	Officer	Dec 15 '25	Proposed Sale	29.86	14,812	442,294		Dec 15 05:38 PM
DALE MICHAEL D	Chief Executive Officer	Dec 10 '25	Sale	30.00	25,000	750,000	63,537	Dec 12 04:06 PM
Began Marc A	EVP & General Counsel	Dec 11 '25	Sale	30.00	13,222	396,660	18,285	Dec 12 04:05 PM
MARC BEGAN	Officer	Dec 11 '25	Proposed Sale	30.00	13,222	396,660		Dec 11 04:08 PM
DALE MICHAEL D	Chief Executive Officer	Dec 09 '25	Sale	31.21	61,463	1,918,137	88,537	Dec 10 05:21 PM
TYNDALL JOSEPH A.	Director	Dec 09 '25	Option Exercise	8.73	25,108	219,223	25,108	Dec 10 05:20 PM
TYNDALL JOSEPH A.	Director	Dec 09 '25	Sale	30.98	25,108	777,771	0	Dec 10 05:20 PM
DeVinney Erick Wayne	Chief Innovation Officer	Dec 09 '25	Sale	31.21	19,517	609,087	241,132	Dec 10 05:20 PM
Kemp Jens	Chief Marketing Officer	Dec 09 '25	Sale	31.21	8,156	254,532	46,030	Dec 10 05:20 PM
Began Marc A	EVP & General Counsel	Dec 09 '25	Sale	31.21	9,278	289,548	31,507	Dec 10 05:19 PM
THOMAS PAUL	Director	Dec 09 '25	Sale	29.61	21,399	633,710	13,528	Dec 10 05:19 PM
JOHNSON JOHN	Director	Dec 08 '25	Option Exercise	6.30	11,891	74,913	25,032	Dec 10 05:19 PM
JOHNSON JOHN	Director	Dec 09 '25	Option Exercise	6.30	8,545	53,834	21,686	Dec 10 05:19 PM
JOHNSON JOHN	Director	Dec 08 '25	Sale	31.24	23,693	740,203	13,141	Dec 10 05:19 PM
JOHNSON JOHN	Director	Dec 09 '25	Sale	29.98	21,686	650,190	0	Dec 10 05:19 PM
Hartley Lindsey Marie	CFO	Dec 08 '25	Option Exercise	13.82	25,000	345,400	45,763	Dec 10 05:18 PM
Hartley Lindsey Marie	CFO	Dec 08 '25	Sale	31.56	14,387	454,005	31,376	Dec 10 05:18 PM
MICHAEL DALE	Officer	Dec 10 '25	Proposed Sale	30.00	25,000	750,000		Dec 10 04:19 PM
PAUL THOMAS	Director	Dec 09 '25	Proposed Sale	29.61	21,399	633,710		Dec 09 04:40 PM
JOSEPH A TYNDALL	Director	Dec 09 '25	Proposed Sale	30.98	25,108	777,771		Dec 09 04:39 PM
JOHN H JOHNSON	Director	Dec 09 '25	Proposed Sale	29.98	21,686	650,186		Dec 09 04:05 PM
JOHN H JOHNSON	Director	Dec 08 '25	Proposed Sale	31.24	23,693	740,207		Dec 08 06:21 PM
LINDSEY MARIE HARTLEY	Officer	Dec 08 '25	Proposed Sale	31.56	14,387	454,009		Dec 08 04:32 PM
Burke William P. Mr.	Director	Nov 10 '25	Option Exercise	8.14	19,227	156,508	19,327	Nov 13 04:31 PM
Burke William P. Mr.	Director	Nov 11 '25	Option Exercise	8.14	3,591	29,231	3,691	Nov 13 04:31 PM
Burke William P. Mr.	Director	Nov 10 '25	Sale	24.01	19,227	461,640	100	Nov 13 04:31 PM
Burke William P. Mr.	Director	Nov 11 '25	Sale	24.02	3,591	86,249	100	Nov 13 04:31 PM
WILLIAM BURKE	Director	Nov 11 '25	Proposed Sale	24.00	3,591	86,184		Nov 12 07:05 AM
WILLIAM BURKE	Director	Nov 10 '25	Proposed Sale	23.57	19,227	453,180		Nov 10 04:30 PM
Burke William P. Mr.	Director	Nov 05 '25	Option Exercise	8.14	11,431	93,048	11,531	Nov 07 04:52 PM
Burke William P. Mr.	Director	Nov 06 '25	Option Exercise	8.14	5,347	43,525	5,447	Nov 07 04:52 PM
Burke William P. Mr.	Director	Nov 05 '25	Sale	24.05	11,431	274,893	100	Nov 07 04:52 PM
Burke William P. Mr.	Director	Nov 06 '25	Sale	24.01	5,347	128,371	100	Nov 07 04:52 PM
WILLIAM BURKE	Director	Nov 06 '25	Proposed Sale	23.38	5,347	125,013		Nov 06 04:20 PM
WILLIAM BURKE	Director	Nov 05 '25	Proposed Sale	23.77	11,431	271,715		Nov 05 04:20 PM
Burke William P. Mr.	Director	Oct 29 '25	Option Exercise	7.21	40,235	289,911	20,536	Oct 31 04:09 PM
Burke William P. Mr.	Director	Oct 30 '25	Option Exercise	7.04	18,248	128,466	18,348	Oct 31 04:09 PM
Burke William P. Mr.	Director	Oct 29 '25	Sale	20.55	40,235	827,013	100	Oct 31 04:09 PM
Burke William P. Mr.	Director	Oct 30 '25	Sale	23.00	18,248	419,704	100	Oct 31 04:09 PM
WILLIAM BURKE	Director	Oct 30 '25	Proposed Sale	22.25	18,248	406,018		Oct 30 04:16 PM
WILLIAM BURKE	Director	Oct 29 '25	Proposed Sale	18.08	36,162	653,809		Oct 29 04:25 PM
Burke William P. Mr.	Director	Oct 22 '25	Sale	18.02	1,457	26,252	100	Oct 24 04:09 PM
Burke William P. Mr.	Director	Oct 22 '25	Proposed Sale	18.02	1,457	26,252		Oct 22 04:41 PM
Burke William P. Mr.	Director	Oct 06 '25	Sale	18.00	736	13,249	1,557	Oct 07 05:18 PM
Burke William P. Mr.	Director	Oct 03 '25	Sale	18.21	14,571	265,283	2,293	Oct 06 04:54 PM
Burke William P. Mr.	Director	Oct 03 '25	Sale	18.21	7,600	138,367	0	Oct 06 04:54 PM
Burke William P. Mr.	Director	Oct 02 '25	Sale	18.01	7,620	137,200	16,864	Oct 06 04:54 PM
Burke William P. Mr.	Director	Oct 02 '25	Sale	18.01	2,400	43,224	7,600	Oct 06 04:54 PM
Burke William P. Mr.	Director	Oct 06 '25	Proposed Sale	18.00	736	13,249		Oct 06 04:54 PM
WILLIAM BURKE	Director	Oct 03 '25	Proposed Sale	17.88	14,937	267,074		Oct 03 04:36 PM
Burke William P. Mr.	Director	Oct 03 '25	Proposed Sale	18.25	11,307	206,317		Oct 03 04:29 PM
Burke William P. Mr.	Director	Oct 02 '25	Proposed Sale	18.01	2,400	43,224		Oct 02 04:24 PM
WILLIAM BURKE	Director	Oct 02 '25	Proposed Sale	17.87	7,620	136,169		Oct 02 04:21 PM
DeVinney Erick Wayne	Chief Innovation Officer	Sep 16 '25	Sale	16.29	1,137	18,522	220,649	Sep 16 05:22 PM
Weiler Kathy Johnson	Director	Jun 09 '25	Sale	10.61	4,073	43,215	6,580	Jun 11 04:27 PM
Levine Alan M	Director	Jun 09 '25	Sale	10.61	4,073	43,215	36,743	Jun 11 04:26 PM
Wendell Amy McBride	Director	Jun 09 '25	Sale	10.61	4,073	43,215	93,826	Jun 11 04:26 PM
Burke William P. Mr.	Director	Jun 09 '25	Sale	10.61	4,073	43,215	24,484	Jun 11 04:25 PM
NEELS GUIDO J	Director	Jun 09 '25	Sale	10.61	4,073	43,215	86,743	Jun 11 04:24 PM
JOHNSON JOHN	Director	Jun 09 '25	Sale	10.61	4,073	43,215	24,943	Jun 11 04:23 PM
TYNDALL JOSEPH A.	Director	Jun 10 '25	Option Exercise	6.56	11,586	75,952	26,931	Jun 11 04:22 PM
TYNDALL JOSEPH A.	Director	Jun 10 '25	Sale	10.72	26,931	288,700	0	Jun 11 04:22 PM
JOSEPH A TYNDALL	Director	Jun 10 '25	Proposed Sale	10.72	26,931	288,814		Jun 10 05:41 PM
TYNDALL JOSEPH A.	Director	May 22 '25	Option Exercise	6.30	12,850	80,955	35,407	May 23 04:32 PM
TYNDALL JOSEPH A.	Director	May 22 '25	Sale	11.20	20,062	224,694	15,345	May 23 04:32 PM
TYNDALL JOSEPH A.	Director	May 19 '25	Sale	11.63	2,525	29,366	22,557	May 23 04:12 PM
TYNDALL JOSEPH A.	Director	May 22 '25	Proposed Sale	11.15	32,339	360,580		May 22 05:14 PM
DeVinney Erick Wayne	Chief Innovation Officer	Mar 16 '25	Option Exercise	0.00	32,462	0	232,873	Mar 19 05:24 PM
DeVinney Erick Wayne	Chief Innovation Officer	Mar 19 '25	Sale	17.50	15,111	264,442	217,762	Mar 19 05:24 PM
Began Marc A	EVP & General Counsel	Mar 01 '25	Option Exercise	0.00	22,500	0	24,186	Mar 05 06:24 PM
Wendell Amy McBride	Director	Mar 03 '25	Sale	20.02	5,000	100,100	97,899	Mar 05 06:20 PM
DeVinney Erick Wayne	Chief Innovation Officer	Feb 28 '25	Option Exercise	0.00	24,799	0	209,301	Mar 04 07:22 PM
AMY MCBRIDE-WENDELL	Director	Mar 03 '25	Proposed Sale	20.01	5,000	100,050		Mar 03 04:16 PM
Kemp Jens	Chief Marketing Officer	Feb 22 '25	Option Exercise	0.00	2,500	0	2,500	Feb 26 04:25 PM

AMWL American Well Corporation daily Stock Chart

Peers: TDOC GDRX DOCS OMCL HIMS CLOV EHTH GH MOH CNC

| Held by: VTI VXF DFAS PRFZ AVSC

Index	-	P/E	-	EPS (ttm)	-7.20	Insider Own	21.77%	Shs Outstand	14.67M	Perf Week	-1.14%
Market Cap	71.22M	Forward P/E	-	EPS next Y	-4.85	Insider Trans	-1.76%	Shs Float	12.81M	Perf Month	-12.30%
Enterprise Value	-111.76M	PEG	-	EPS next Q	-1.80	Inst Own	40.41%	Short Float	1.28%	Perf Quarter	7.67%
Income	-113.43M	P/S	0.27	EPS this Y	55.58%	Inst Trans	5.49%	Short Ratio	1.45	Perf Half Y	-38.39%
Sales	265.02M	P/B	0.28	EPS next Y	21.31%	ROA	-26.93%	Short Interest	0.16M	Perf YTD	-11.41%
Book/sh	15.62	P/C	0.35	EPS next 5Y	38.20%	ROE	-38.35%	52W High	12.95 -66.41%	Perf Year	-62.07%
Cash/sh	12.27	P/FCF	-	EPS past 3/5Y	0.01% -12.84%	ROIC	-44.19%	52W Low	3.71 17.25%	Perf 3Y	-93.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.21% 11.31%	Gross Margin	39.71%	Volatility	5.72% 5.61%	Perf 5Y	-99.34%
Dividend TTM	-	EV/Sales	-0.42	EPS Y/Y TTM	50.50%	Oper. Margin	-41.36%	ATR (14)	0.27	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.08	Sales Y/Y TTM	4.33%	Profit Margin	-42.80%	RSI (14)	42.99	Recom	2.75
Dividend Gr. 3/5Y	- -	Current Ratio	3.10	EPS Q/Q	30.47%	SMA20	-4.96%	Beta	1.40	Target Price	6.60
Payout	-	Debt/Eq	0.02	Sales Q/Q	-7.80%	SMA50	-5.18%	Rel Volume	0.77	Prev Close	4.41
Employees	877	LT Debt/Eq	0.01	Earnings	Feb 12 AMC	SMA200	-29.04%	Avg Volume	113.08K	Price	4.35
IPO	Sep 17, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-10.27% 2.22%	Trades		Volume	81,137	Change	-1.36%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-13-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$15
Aug-03-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$5 → $2.50
Mar-23-23	Downgrade	TD Cowen	Outperform → Market Perform	$5 → $2.50
Feb-27-23	Downgrade	Piper Sandler	Overweight → Neutral	$5 → $3.50
Jan-04-23	Upgrade	BofA Securities	Neutral → Buy	$4.20
Sep-07-22	Initiated	Truist	Hold	$5
Apr-14-22	Initiated	Guggenheim	Buy	$6
Apr-01-22	Resumed	Credit Suisse	Neutral	$5
Feb-11-22	Initiated	Goldman	Neutral	$6
Dec-02-21	Initiated	Jefferies	Hold	$6
Oct-19-21	Initiated	Wells Fargo	Equal Weight	$8
Sep-14-21	Initiated	Cantor Fitzgerald	Overweight	$15
May-17-21	Upgrade	Guggenheim	Neutral → Buy	$15
Apr-16-21	Initiated	KeyBanc Capital Markets	Sector Weight
Apr-15-21	Initiated	Needham	Hold
Jan-28-21	Downgrade	Credit Suisse	Outperform → Neutral	$41
Jan-07-21	Initiated	BTIG Research	Neutral
Dec-18-20	Initiated	Stifel	Hold	$29
Nov-18-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$26
Oct-23-20	Initiated	Guggenheim	Neutral

Show Previous Ratings

Today 07:37AM	Earnings To Watch: American Well Corp (AMWL) Reports Q4 2025 Result (GuruFocus.com)
Feb-05-26 04:05PM	Amwell to report fourth quarter and full year 2025 operating results (GlobeNewswire)
Jan-19-26 12:13PM	Hims & Hers Expands Platform-Led Access to Digital Healthcare (Zacks)
Dec-23-25 11:45AM	Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows (Zacks)
Dec-03-25 10:28AM	Hims & Hers Expands Care Scope as Prescription Platforms Evolve (Zacks)
11:43AM	Loading…
Nov-18-25 11:43AM	Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? (Zacks)
Nov-11-25 12:43PM	Hims & Hers Scales Technology-Enabled, Vertically Integrated Care (Zacks)
Nov-05-25 12:11AM	American Well Corp (AMWL) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) -9.50%
Nov-04-25 08:00PM	Compared to Estimates, American Well (AMWL) Q3 Earnings: A Look at Key Metrics (Zacks)
07:15PM	American Well Corporation (AMWL) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Amwell Announces Results for Third Quarter 2025 (GlobeNewswire)
Nov-03-25 08:12AM	Earnings To Watch: American Well Corp (AMWL) Reports Q3 2025 Result (GuruFocus.com)
Oct-31-25 07:38AM	Harry Yous Berto Embraces Clinic-in-a-Box with OnMed Event Flash (Exec Edge)
Oct-27-25 04:35PM	Amwell to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences (GlobeNewswire)
Oct-22-25 10:40AM	Hims & Hers Advances AI-Powered Personalized Digital Healthcare (Zacks)
01:13PM	Loading…
Oct-14-25 01:13PM	Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell? (Zacks)
Oct-03-25 09:58AM	Hims & Hers Expands Health Access Through Subscription Revenue Model (Zacks)
07:40AM	From Apps to Nutrition: Health & Fitness Stocks to Buy Now (Zacks)
Sep-12-25 10:02AM	Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock? (Zacks)
Sep-08-25 11:10AM	Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem (Zacks)
Aug-28-25 10:08AM	HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? (Zacks)
Aug-19-25 10:01AM	Hims & Hers Fuels Growth via Market Expansion and New Care Verticals (Zacks)
Aug-13-25 12:43PM	Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? (Zacks)
Aug-08-25 04:05PM	Amwell makes grant to new employees under inducement plan (GlobeNewswire)
Aug-05-25 08:00PM	American Well (AMWL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) +20.45% -7.31%
07:05PM	American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Amwell Announces Results for Second Quarter 2025 (GlobeNewswire)
08:30AM	Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System ("MHS") (GlobeNewswire)
Aug-04-25 10:11AM	What To Expect From American Well Corp (AMWL) Q2 2025 Earnings (GuruFocus.com)
Jul-24-25 08:00AM	American Well (AMWL) Soars 5.0%: Is Further Upside Left in the Stock? (Zacks)
05:28AM	Loading…
Jul-23-25 05:28AM	The Zacks Analyst Blog Highlights Hims & Hers Health, Teladoc Health and American Well (Zacks) +5.01%
Jul-22-25 04:05PM	Amwell to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences (GlobeNewswire)
12:29PM	Hims & Hers Paves the Way for Global Digital Health Expansion (Zacks)
Jul-17-25 11:28AM	Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally? (Zacks)
Jul-01-25 08:50AM	Why Fast-paced Mover American Well (AMWL) Is a Great Choice for Value Investors (Zacks) -5.51%
Jun-26-25 08:49AM	Does DOCS' Shift Toward Enterprise Offerings Signal a Long-Term Pivot? (Zacks)
Jun-23-25 01:53PM	BlackSky Technology (BKSY) Surges 11.9%: Is This an Indication of Further Gains? (Zacks)
01:33PM	Adeia (ADEA) Moves 5.2% Higher: Will This Strength Last? (Zacks)
01:17PM	Zeta (ZETA) Surges 12.6%: Is This an Indication of Further Gains? (Zacks)
09:20AM	Lemonade (LMND) Moves 9.4% Higher: Will This Strength Last? (Zacks)
09:07AM	Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last? (Zacks)
08:35AM	Evolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar? (Zacks)
07:56AM	Strength Seen in Wendy's (WEN): Can Its 6.0% Jump Turn into More Strength? (Zacks)
06:36AM	Granite Ridge Resources, Inc. (GRNT) Surges 6.7%: Is This an Indication of Further Gains? (Zacks)
03:14AM	GXO Logistics (GXO) Soars 12.1%: Is Further Upside Left in the Stock? (Zacks)
Jun-19-25 12:09PM	Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now? (Zacks)
Jun-05-25 12:20PM	HIMS' Buyouts Fuel International Expansion & Digital Health Innovation (Zacks)
Jun-04-25 12:10PM	Top Stock Movers Now: DR Horton, Wells Fargo, Dollar Tree, and More (Investopedia)
May-30-25 12:21PM	Hims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy? (Zacks)
May-06-25 04:05PM	Amwell makes grant to new employee under inducement plan (GlobeNewswire) -7.11%
12:00PM	All You Need to Know About American Well (AMWL) Rating Upgrade to Buy (Zacks)
09:55AM	Does American Well (AMWL) Have the Potential to Rally 46.51% as Wall Street Analysts Expect? (Zacks)
09:40AM	Is American Well (AMWL) Outperforming Other Medical Stocks This Year? (Zacks)
May-02-25 10:05AM	Amwell narrows losses in Q1 amid military contract rollout (Healthcare Dive) +19.71%
03:20AM	American Well Corp (AMWL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
May-01-25 08:05PM	American Well Corporation (AMWL) Q1 2025 Earnings Call Transcript (Seeking Alpha) -15.55%
07:00PM	American Well (AMWL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:25PM	American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Amwell Announces Results for First Quarter 2025 (GlobeNewswire)
Apr-24-25 07:30AM	Amwell to participate in upcoming investor conferences (GlobeNewswire)
Apr-17-25 07:05AM	Amwell to report first quarter 2025 operating results (GlobeNewswire)
Mar-03-25 04:05PM	Amwell makes inducement grant (GlobeNewswire) -12.15%
08:05AM	Amwell announces innovation leader as chief product and technology officer (GlobeNewswire)
05:12AM	Amwell names Amazon vet to chief product and technology role (Healthcare Dive)
Feb-21-25 09:22AM	Amwell makes grants to new employees under inducement plan (GlobeNewswire)
Feb-19-25 04:05PM	Amwell to participate in upcoming investor conference (GlobeNewswire)
Feb-13-25 10:58AM	Q4 2024 American Well Corp Earnings Call (Thomson Reuters StreetEvents) -5.02%
03:54AM	Amwell touts military contract deployment wins in Q4 (Healthcare Dive)
02:17AM	American Well Corp (AMWL) Q4 2024 Earnings Call Highlights: Strategic Gains Amidst Revenue ... (GuruFocus.com)
Feb-12-25 11:00PM	American Well (AMWL) Q4 2024 Earnings Call Transcript (Motley Fool) +7.67%
07:30PM	Compared to Estimates, American Well (AMWL) Q4 Earnings: A Look at Key Metrics (Zacks)
05:35PM	American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Amwell Announces Results for Fourth Quarter and Full Year 2024 (GlobeNewswire)
Feb-11-25 09:15AM	American Well (AMWL) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Jan-29-25 07:00AM	Amwell to report fourth quarter and full year 2024 operating results (GlobeNewswire)
Jan-15-25 08:05AM	Amwell adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care (GlobeNewswire) +5.64%
Jan-14-25 06:08AM	Strength Seen in American Well (AMWL): Can Its 18.8% Jump Turn into More Strength? (Zacks) -6.99%
Jan-10-25 08:10AM	Amwell divests virtual psychiatric care business for $21M and added earn-out (TipRanks)
Jan-09-25 12:18PM	Amwell divests virtual psychiatric care business for $21m to boost cash flow (Medical Device Network)
09:11AM	Amwell sells virtual psychiatric care business to Avel eCare for $21M (Healthcare Dive)
08:12AM	Avel eCare Announces Acquisition of Amwell Psychiatric Care to Expand Telemedicine Services (ACCESS Newswire)
08:00AM	Amwell divests virtual psychiatric care business to Avel eCare in all-cash transaction (GlobeNewswire)
Dec-18-24 04:30PM	Amwell CFO Mark Hirschhorn Expands Leadership Role (GlobeNewswire) -6.98%
Nov-04-24 04:05PM	Amwell Makes Grants to New Employees Under Inducement Plan (GlobeNewswire)
Oct-31-24 05:00AM	American Well Corp (AMWL) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... (GuruFocus.com) -5.08%
02:00AM	American Well (AMWL) Q3 2024 Earnings Call Transcript (Motley Fool)
Oct-30-24 08:00PM	American Well (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:55PM	American Well Corporation (AMWL) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Amwell Announces Results for Third Quarter 2024 (GlobeNewswire)
Oct-29-24 09:17AM	American Well Corp (AMWL) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-28-24 07:00AM	Amwell to participate in upcoming investor conferences (GlobeNewswire) +5.53%
Oct-23-24 10:01AM	American Well Corporation (AMWL) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-16-24 05:18AM	Amwell taps ex-Teladoc exec as CFO (Healthcare Dive)
Oct-15-24 04:30PM	Amwell announces new chief financial officer (GlobeNewswire)
07:05AM	Amwell to report third quarter 2024 operating results (GlobeNewswire)
Oct-08-24 07:05AM	Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution (GlobeNewswire)
Aug-22-24 04:05PM	Amwell to Participate in Upcoming Investor Conferences (GlobeNewswire) +7.38%
Aug-05-24 03:33PM	3 Telemedicine Stocks Poised for Possible Healthcare Evolution (InvestorPlace) -13.48%
Aug-01-24 10:26AM	Amwell boosts 2024 adjusted earnings outlook, narrows net loss in Q2 (Healthcare Dive) +40.20%
12:45AM	American Well (AMWL) Q2 2024 Earnings Call Transcript (Motley Fool)

American Well Corp. engages in the provision of online healthcare services. It offers a single platform to support all telehealth needs from urgent to acute and post-acute care, chronic care management, and healthy living. Its services include urgent care, behavioral health, breastfeeding support, chronic care, nutrition counseling, pediatrics, telestroke, and virtual primary care. The company was founded by Ido Schoenberg and Roy Schoenberg in June 2006 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zamansky Dmitry	Chief Product & Tech. Officer	Jan 02 '26	Sale	4.85	6,243	30,279	191,468	Jan 05 05:09 PM
Gotlib Phyllis	President, International	Jan 02 '26	Sale	4.85	3,707	17,979	119,870	Jan 05 05:04 PM
McNeice Paul Francis	Chief Accounting Officer	Jan 02 '26	Sale	4.85	384	1,862	3,063	Jan 05 04:58 PM
Dmitry Zamansky	Officer	Jan 02 '26	Proposed Sale	4.85	6,243	30,285		Jan 02 04:37 PM
Phyllis Gotlib	Officer	Jan 02 '26	Proposed Sale	4.85	3,707	17,983		Jan 02 04:32 PM
Jackson Deborah C	Director	Dec 18 '25	Sale	4.71	612	2,883	0	Dec 22 06:19 PM
McNeice Paul Francis	Chief Accounting Officer	Dec 01 '25	Sale	4.06	113	458	3,447	Dec 03 04:41 PM
Gotlib Phyllis	President, International	Dec 01 '25	Sale	4.06	3,574	14,501	123,577	Dec 03 04:38 PM
Phyllis Gotlib	Officer	Dec 01 '25	Proposed Sale	4.06	3,574	14,501		Dec 01 04:26 PM
McNeice Paul Francis	Chief Accounting Officer	Oct 01 '25	Sale	6.11	332	2,027	3,560	Oct 03 04:40 PM
Gotlib Phyllis	President, International	Oct 01 '25	Sale	6.11	4,959	30,282	127,151	Oct 03 04:40 PM
Phyllis Gotlib	Officer	Oct 01 '25	Proposed Sale	6.11	4,959	30,282		Oct 01 04:34 PM
Jackson Deborah C	Director	Sep 15 '25	Sale	6.56	4,531	29,745	39,132	Sep 17 05:33 PM
Zamansky Dmitry	Chief Product & Tech. Officer	Sep 03 '25	Sale	6.77	25,605	173,407	197,711	Sep 04 08:00 PM
Jackson Deborah C	Director	Sep 02 '25	Sale	6.79	4,531	30,759	43,663	Sep 04 07:59 PM
Gotlib Phyllis	President, International	Sep 02 '25	Sale	6.78	4,781	32,422	132,110	Sep 04 07:57 PM
McNeice Paul Francis	Chief Accounting Officer	Sep 02 '25	Sale	6.78	113	766	3,892	Sep 04 07:57 PM
Dmitry Zamansky	Officer	Sep 03 '25	Proposed Sale	6.82	26,500	180,661		Sep 03 04:53 PM
Phyllis Gotlib	Officer	Sep 02 '25	Proposed Sale	6.78	4,781	32,422		Sep 02 05:07 PM
Jackson Deborah C	Director	Aug 19 '25	Sale	7.10	4,531	32,182	48,194	Aug 21 05:01 PM
DEBORAH JACKSON	Director	Aug 19 '25	Proposed Sale	7.25	13,593	98,549		Aug 19 04:26 PM
Gotlib Phyllis	President, International	Jul 01 '25	Sale	8.63	4,958	42,773	136,891	Jul 01 04:35 PM
McNeice Paul Francis	Chief Accounting Officer	Jul 01 '25	Sale	8.63	331	2,856	14,005	Jul 01 04:34 PM
Phyllis Gotlib	Officer	Jul 01 '25	Proposed Sale	8.63	4,958	42,773		Jul 01 04:33 PM
McNeice Paul Francis	Chief Accounting Officer	Jun 02 '25	Sale	6.61	113	747	14,366	Jun 04 05:01 PM
Gotlib Phyllis	President, International	Jun 02 '25	Sale	6.61	4,782	31,628	141,849	Jun 04 05:01 PM
Phyllis Gotlib	Officer	Jun 02 '25	Proposed Sale	6.61	4,782	31,628		Jun 02 04:49 PM
Gotlib Phyllis	President, International	May 01 '25	Sale	7.21	299	2,155	146,631	May 05 04:31 PM
McNeice Paul Francis	Chief Accounting Officer	May 01 '25	Sale	7.21	8	58	14,479	May 05 04:31 PM
Phyllis Gotlib	Officer	May 01 '25	Proposed Sale	7.21	299	2,155		May 01 04:32 PM
McNeice Paul Francis	Chief Accounting Officer	Apr 01 '25	Sale	7.28	96	699	14,487	Apr 03 04:39 PM
Gotlib Phyllis	President, International	Apr 01 '25	Sale	7.28	1,068	7,775	146,930	Apr 03 04:37 PM
Phyllis Gotlib	Officer	Apr 01 '25	Proposed Sale	7.28	1,068	7,775		Apr 01 05:53 PM
McNeice Paul Francis	Chief Accounting Officer	Mar 03 '25	Sale	8.80	130	1,144	14,583	Mar 05 05:13 PM
Gotlib Phyllis	President, International	Mar 03 '25	Sale	8.80	4,781	42,061	147,998	Mar 05 05:13 PM
Vukasin Paunovich	Officer	Mar 03 '25	Proposed Sale	9.36	19,700	184,418		Mar 03 06:49 PM
Phyllis Gotlib	Officer	Mar 03 '25	Proposed Sale	9.36	5,500	51,487		Mar 03 06:48 PM

AXGN

Axogen Inc

AMWL

American Well Corporation

Upgrade your FINVIZ experience